CD4+ CTL and CD8+ T cells in SSc may contribute to excessive tissue remodeling by targeting endothelial cells and refining proinflammatory molecules such as IL-1β, leading to vascular damage and tissue fibrosis (31). The gene discussed is IL1B; the disease is systemic sclerosis.